Author:
Elewski Boni E.,Lebwohl Mark G.,Anadkat Milan J.,Barker Jonathan,Ghoreschi Kamran,Imafuku Shinichi,Mrowietz Ulrich,Li Ling,Quaresma Manuel,Thoma Christian,Bachelez Hervé
Funder
Boehringer Ingelheim International GmbH
Boehringer Ingelheim
Reference19 articles.
1. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare;Choon;BMJ Open,2021
2. Trial of spesolimab for generalized pustular psoriasis;Bachelez;N Engl J Med,2021
3. Spesolimab prescribing information,2022
4. European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares,2022
5. First-ever treatment aimed at alleviating acute symptoms in pustular psoriasis [media release],2022
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献